Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Indexé dans
  • Index Copernic
  • Google Scholar
  • Ouvrir la porte J
  • JournalSeek de génamique
  • Infrastructure nationale du savoir de Chine (CNKI)
  • Bibliothèque de revues électroniques
  • Recherche de référence
  • Université Hamdard
  • EBSCO AZ
  • OCLC-WorldCat
  • Bibliothèque virtuelle de biologie (vifabio)
  • Publons
  • Fondation genevoise pour l'enseignement et la recherche médicale
  • Euro Pub
  • ICMJE
Partager cette page

Abstrait

Improvement in Quality of Life in Survivors of Chronic Obstructive Pulmonary Disease with Minimal Interventions

Prateek Upadhyay, Prashant Ahlawat

The global health care burden of Chronic Obstructive Pulmonary Disease (COPD) is enormous. Patients who are battling COPD have a very poor quality of life and suffer physically, mentally, emotionally, socially, and spiritually. Many treatment modalities have been in practice for a long time, but have limitations. The consequence of disregard for quality of life has generated a lot of unmet needs for patients. These patients deserve a good quality of life and a timely institution of palliative care to maintain the continuum of care. This article aims to highlight novel modalities, preferably non invasive or minimally invasive, that can be used to alleviate the suffering of patients with COPD. Lung flute is slowly finding its way into routine clinical practice for palliation of patients with COPD. It has the potential to be used as effortlessly as a hand-held incentive spirometer that is used in hospitals day in and day out. Bronchoscopic Lung Volume Reduction or Valve Surgery, Targeted Lung Denervation therapy, Metered Cryospray in addition to research on Stem Cell therapy are novel measures with hopeful and promising results so far to improve the quality of life of COPD survivors.